Physician profile
Kris Dinucci
NPI 1669416210
$1,371,995.78
in general payments reported to CMS, 2019-2025
10 companies · $237K in 2025
The $237K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148K · 2020: $140K · 2021: $176K · 2022: $266K · 2023: $198K · 2024: $208K · 2025: $237K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $570K · Consulting Fee: $52K · Acquisitions: $12K · Travel and Lodging: $6,098 · Food and Beverage: $1,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $570,237.72 |
| Consulting Fee | $51,880.00 |
| Acquisitions | $12,387.68 |
| Travel and Lodging | $6,098.12 |
| Food and Beverage | $1,630.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,201,830.11 | 2019-2025 | Arthrex |
| Linvatec Corporation | $104,329.53 | 2022-2024 | Avenger Radial Head, +4 Stems |
| Voom Medical Devices, INC. | $54,097.84 | 2023-2025 | Revcon Instrument Kit, Sterile, Revcon, Voom Medical Revcontm Screw System |
| Fusion Orthopedics USA, LLC | $5,343.64 | 2023-2024 | |
| In2bones USA, LLC | $5,011.73 | 2020-2021 | |
| Impactortho, INC. | $1,200.00 | 2021 | |
| Abbott Laboratories | $82.87 | 2025 | Prodigy |
| Smith+Nephew, INC. | $46.57 | 2023 | Panta 2, Evos Mini |
| Bioventus LLC | $37.26 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $16.23 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Dinucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.